ADCON-L ADHESION CONTROL IN A BARRIER GEL

Inhibitor, Peridural Fibrosis (adhesion Barrier)

FDA Premarket Approval P960057 S008

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval for new quality control measures and is indicated for use during single level, posterior lumbar laminectomy or laminotomy procedures where nerve roots are exposed to inhibit postsurgical peridural fibrosis.

DeviceADCON-L ADHESION CONTROL IN A BARRIER GEL
Classification NameInhibitor, Peridural Fibrosis (adhesion Barrier)
Generic NameInhibitor, Peridural Fibrosis (adhesion Barrier)
ApplicantWRIGHTMEDICALTECHNOLOGYINC
Date Received1999-05-13
Decision Date1999-06-02
PMAP960057
SupplementS008
Product CodeMLQ
Advisory CommitteePhysical Medicine
Supplement TypeSpecial (immediate Track)
Supplement ReasonProcess Change - Manufacturer/sterilizer/packager/supplier
Expedited ReviewNo
Combination Product No
Applicant Address WRIGHTMEDICALTECHNOLOGYINC 5677 Airline Rd. arlinton, TN 38002

Supplemental Filings

Supplement NumberDateSupplement Type
P960057Original Filing
S011 2000-06-26 Special (immediate Track)
S010
S009
S008 1999-05-13 Special (immediate Track)
S007
S006 1999-03-12 Real-time Process
S005 1999-02-19 135 Review Track For 30-day Notice
S004 1999-02-11 Normal 180 Day Track
S003 1998-12-21 30-day Notice
S002 1998-11-03 Real-time Process
S001 1998-08-28 30-day Notice

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.